Vagisan

Medicinal product

(Invented) name

Vagisan

Active substance (s)

(S)-pieno rūgštis/Natrio laktatas

Strength

167 mg/100 mg

Pharmaceutical form

ovulės

Route (s) of administration

vartoti į makštį

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G01AD01, Lactic acid

Marketing authorisation holder

Dr. August Wolff GmbH & Co. KG Arzneimittel, Vokietija

Date of authorisation

1999-07-02

Date of renewal

2014-05-07

Documents

0504 Pakuotės lapelis 2025 02 14.docx

0504 Vagisan RPP 2025 02 14.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Ovulėje yra	1 vnt.
(S)-pieno rūgštis	167 mg
Natrio laktatas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
18350	22004	1022004	lizdinė plokštelė	N7		Nereceptinis	LT/1/99/0504/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-05-07	Perregistruotas
1999-07-02	Registruotas